What do you mean..."nothing new?"
This quarter was an absolute cracker. FDA approval for Sofdra. $70 Mil raised and $80 mil in the bank to fund launch and commercialization.
For devout followers of the company, this news has all been released , but this is company-making stuff!
Great story, great management, fully funded to the tune of 80Mil.
Clear runway to revenue generation and growth...Bot will become more and more attractive to Institutional funds as the price increases and it grows in MC over 1b.
Many funds cant touch anything under 1b or with minimal revenue. Bot has truly flipped the script this quarter and is on track to become big enough and profitable enough to warrant investment.
What do you mean..."nothing new?" This quarter was an absolute...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $752.8M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 43.5¢ | 41.0¢ | $2.989M | 7.071M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 408524 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |